Maher Albitar/LinkedIn
Jan 9, 2025, 12:32
Liquid Transcriptomics and AI: Transforming Cancer Diagnosis – International Society of Liquid Biopsy
International Society of Liquid Biopsy shared a post on X:
“Liquid Transcriptomics and AI: Transforming Cancer Diagnosis.
Key Insights:
Combining cfRNA with AI achieves high diagnostic accuracy in solid tumors, myeloid, and lymphoid neoplasms.
AUC Results:
- Solid Tumors: 0.86
- Myeloid Neoplasms: 0.86
- Lymphoid Neoplasms: 0.79
Liquid biopsy could evolve into a true biopsy, reducing the need for tissue biopsies.”
Authors: Maher Albitar, Ahmad Charifa, Sally Agersborg, Andrew Pecora, Andrew Ip and Andre Goy
More posts featuring the International Society of Liquid Biopsy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 9, 2025, 12:22
Jan 9, 2025, 12:14
Jan 9, 2025, 12:11
Jan 9, 2025, 12:08
Jan 9, 2025, 12:05
Jan 9, 2025, 11:45